Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06599996 · ClinicalTrials.gov registry record · NA
Artificial Intelligence and Augmentative and Alternative Communication AAC
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT06599996: Completed NA study, sponsored by Penn State University.
NCT06599996 is a NA study that has completed, run by Penn State University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06599996, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The overarching objective of this project is to transform access to assistive communication technologies (augmentative and alternative communication) for individuals with motor disabilities and/or visual impairment, for whom natural speech is not meeting their communicative needs. These individuals often cannot access traditional augmentative and alternative communication because of their restricted movement or visual function. However, most such individuals have idiosyncratic body-based means of communication that is reliably interpreted by familiar communication partners. The project will test artificial intelligence algorithms that gather information from sensors or camera feeds about these idiosyncratic movement patterns of the individual with motor/visual impairments. Based on the sensor or camera feed information, the artificial intelligence algorithms will interpret the individual's gestures and translate the interpretation into speech output. For instance, if an individual waves their hand as their means of communicating "I want", the artificial intelligence algorithm will detect that gesture and prompt the speech-generating technology to produce the spoken message "I want." This will allow individuals with restricted but idiosyncratic movements to access the augmentative and alternative communication technologies that are otherwise out of reach.
Primary Outcome
How long it takes participants learn to program the algorithms (number of minutes taken)
Interventions
- DEVICE Testing artificial intelligence algorithms for interpreting gestures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2024-09-24 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
What the finished NCT06599996 record still lists
NCT06599996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Testing artificial intelligence algorithms for interpreting gestures is the first listed.
NCT06599996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06599996 about?
NCT06599996 is a clinical study titled "Artificial Intelligence and Augmentative and Alternative Communication AAC". The overarching objective of this project is to transform access to assistive communication technologies (augmentative and alternative communication) for individuals with motor disabilities and/or visual impairment, for whom natural speech is not meeting their communicative needs. These individuals ...
What is the current status of trial NCT06599996?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2024-09-24. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT06599996?
The interventions under investigation include: Testing artificial intelligence algorithms for interpreting gestures (DEVICE).
Who is sponsoring clinical trial NCT06599996?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06599996's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI